Sep. 20 at 2:06 AM
Everyone should have
$PMCB on top watch
$PMCB is a deeply discounted biotech with serious 20x potential, sitting near bottom with a derisked setup and massive upside. Its Cell in a Box technology targets hard to treat cancers like inoperable pancreatic cancer by delivering therapy directly to the tumor, aiming to reduce toxicity and improve outcomes. With completed safety studies, a strong cash position from past raises, and a pipeline that also includes malignant ascites and diabetes, PMCB offers multiple shots on goal. If FDA hurdles are cleared and clinical trials succeed, this microcap could quickly re rate and with low expectations baked in, even modest success could trigger explosive upside.
$100 stock one day??
Or just a 10-20x like my
$ORBS $WLDS call
